West Pharmaceutical Services, Inc. Net Income 2008–2025
West Pharmaceutical Services, Inc. reported $493.70M of net income for fiscal 2025. That was 0.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +42.6%.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $493.70M | 16.1% | +0.2% |
| FY 2024 | $492.70M | 17.0% | -17.0% |
| FY 2023 | $593.40M | 20.1% | +1.3% |
| FY 2022 | $585.90M | 20.3% | -11.5% |
| FY 2021 | $661.80M | 23.4% | +91.2% |
| FY 2020 | $346.20M | 16.1% | +43.2% |
| FY 2019 | $241.70M | 13.1% | +16.8% |
| FY 2018 | $206.90M | 12.0% | +37.3% |
| FY 2017 | $150.70M | 9.4% | +4.9% |
| FY 2016 | $143.60M | 9.5% | +50.2% |
| FY 2015 | $95.60M | 6.8% | -24.8% |
| FY 2014 | $127.10M | 8.9% | +13.2% |
| FY 2013 | $112.30M | 8.2% | +39.2% |
| FY 2012 | $80.70M | 6.4% | +6.9% |
| FY 2011 | $75.50M | 6.3% | +15.6% |
| FY 2010 | $65.30M | 5.9% | -10.1% |
| FY 2009 | $72.60M | 6.9% | -15.6% |
| FY 2008 | $86.00M | 8.2% | — |
Source: West Pharmaceutical Services, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open WST 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
West Pharmaceutical Services, Inc. reported $493.70M of net income for fiscal 2025. That was 0.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +42.6%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for West Pharmaceutical Services, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeWest Pharmaceutical Services, Inc. — frequently asked questions
What is West Pharmaceutical Services, Inc.'s net income?
West Pharmaceutical Services, Inc. (WST) reported net income of $493.70M for fiscal year 2025, per its SEC filings.
How has West Pharmaceutical Services, Inc.'s net income changed over time?
Between fiscal 2008 and 2025, WST's net income grew at roughly 10.8% per year (compound annual rate), from $86.00M to $493.70M.
Where does this data come from?
Figures are computed from West Pharmaceutical Services, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.